Media Center

Delivering health equality and sustainable access to medicines for patients in Europe and worldwide

Berlin, June 10, 2015 - In his opening speech at the 21st EGA Annual Conference today, EGA President Nick Haggar said that the European generic and biosimilar industry “is successfully fulfilling its mission to be the main supplier of high-quality medicines to patients in Europe, both increasing patient access and partnering for sustainable healthcare”.

Click here to read the full EGA press release.